Century Therapeutics, Inc. (IPSC) income statement
IPSCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.38+0.01 (+0.73%)
Close on Nov 18, 2026Market cap $249.88MP/E –Yield –
Century Therapeutics, Inc. financial ratios
See a number that looks wrong?